Review
doi: 10.1016/s0168-3659(01)00309-1.
Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS
Affiliations
- PMID: 11489482
- DOI: 10.1016/s0168-3659(01)00309-1
Item in Clipboard
Review
Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS
J Control Release.
.
Abstract
This review article describes three aspects of polymeric drugs. The general mechanism of the EPR (enhanced permeability and retention) effect and factors involved in the effect are discussed, in view of the advantages of macromolecular therapeutics for cancer treatment, which are based on the highly selective EPR-related delivery of drug to tumor. Also described are advantages of more general water-soluble polymeric drugs as primary anticancer agents, using SMANCS as an example. Last, SMANCS/Lipiodol is discussed with reference to the type of formulation for arterial injection with most pronounced tumor selective delivery, as well as its advantages, precautions, and side effects from the clinical standpoint.
Similar articles
-
[Recent advances in research on SMANCS].Gan To Kagaku Ryoho. 1998 Feb;25 Suppl 1:1-9. Gan To Kagaku Ryoho. 1998. PMID: 9512680 Review. Japanese.
-
Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS.Adv Exp Med Biol. 2003;519:29-49. doi: 10.1007/0-306-47932-X_2. Adv Exp Med Biol. 2003. PMID: 12675206 Review.
-
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):169-85. doi: 10.1016/s0169-409x(00)00134-4. Adv Drug Deliv Rev. 2001. PMID: 11259839
-
[SMANCS/lipiodol].Gan To Kagaku Ryoho. 1994 May;21(6):907-13. Gan To Kagaku Ryoho. 1994. PMID: 8185354 Review. Japanese.
-
Intracavitary administration: pharmacokinetic advantages of macromolecular anticancer agents against peritoneal and pleural carcinomatoses.Anticancer Res. 1998 Jul-Aug;18(4A):2547-50. Anticancer Res. 1998. PMID: 9703908
Cited by
-
Silver nanoparticles: Synthesis, medical applications and biosafety.Theranostics. 2020 Jul 11;10(20):8996-9031. doi: 10.7150/thno.45413. eCollection 2020. Theranostics. 2020. PMID: 32802176 Free PMC article. Review.
-
Nanoscale Coordination Polymers Codeliver Carboplatin and Gemcitabine for Highly Effective Treatment of Platinum-Resistant Ovarian Cancer.Mol Pharm. 2016 Nov 7;13(11):3665-3675. doi: 10.1021/acs.molpharmaceut.6b00466. Epub 2016 Oct 21. Mol Pharm. 2016. PMID: 27712076 Free PMC article.
-
Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid).Pharm Res. 2010 Nov;27(11):2317-29. doi: 10.1007/s11095-010-0091-0. Epub 2010 Apr 13. Pharm Res. 2010. PMID: 20387095 Free PMC article.
-
PLGA-Based Nanoparticles in Cancer Treatment.Front Pharmacol. 2018 Nov 2;9:1260. doi: 10.3389/fphar.2018.01260. eCollection 2018. Front Pharmacol. 2018. PMID: 30450050 Free PMC article. Review.
-
Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer.Bioimpacts. 2022;12(6):515-531. doi: 10.34172/bi.2022.23433. Epub 2022 Jan 15. Bioimpacts. 2022. PMID: 36644541 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
